New science in molecular diagnostics, personalized medicine, and genetic testing for cancer will be featured topics when more than 1,000 pathology leaders gather at the Manchester Grand Hyatt on Sept 9 to Sept 12 for the annual scientific meeting of the College of American Pathologists (CAP). CAP ’12—The Pathologists’ Meeting™ will highlight advances in anatomic and clinical pathology related to laboratory medicine with a special focus on pulmonary pathology, the diagnosis of lung disease.

At CAP ’12, pathologists from around the globe will lead educational seminars that provide practical tools, which pathologists can immediately incorporate into their practices.

Topics include breakthroughs in the molecular testing of lung cancer, a disease that strikes more than 230,000 Americans each year. This session will offer perspectives from Marc Ladanyi, MD, FCAP, an attending pathologist on the molecular diagnostics service in the department of pathology at Memorial Sloan-Kettering in New York, and Kim Norris, a UCLA Lung SPORE patient advocate and president of the Lung Cancer Foundation of American.

Additional topics include:

* Next-Generation Sequencing for Inherited Disorders
* Companion Diagnostics for Targeted Therapy Cancer
* Treatment Implication of ER-Positive and HER2-Positive Breast Cancer—The Critical Role of Pathologists
* Molecular Classification of Multiple Myeloma Using Genomic Profiling